These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 17029220)
1. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas. Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220 [TBL] [Abstract][Full Text] [Related]
2. Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours. Dobashi Y; Watanabe H; Matsubara M; Yanagawa T; Raz A; Shimamiya T; Ooi A J Pathol; 2006 Jan; 208(1):44-53. PubMed ID: 16294294 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335 [TBL] [Abstract][Full Text] [Related]
4. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
6. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Volm M; Koomägi R Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513 [TBL] [Abstract][Full Text] [Related]
7. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576 [TBL] [Abstract][Full Text] [Related]
8. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas. Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534 [TBL] [Abstract][Full Text] [Related]
10. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes. Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072 [TBL] [Abstract][Full Text] [Related]
11. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic role of JC virus in lung cancer. Zheng H; Abdel Aziz HO; Nakanishi Y; Masuda S; Saito H; Tsuneyama K; Takano Y J Pathol; 2007 Jul; 212(3):306-15. PubMed ID: 17534844 [TBL] [Abstract][Full Text] [Related]
13. Chromogranin A gene expression in non-small cell lung carcinomas. Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430 [TBL] [Abstract][Full Text] [Related]
14. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Watanabe H; Takehana K; Date M; Shinozaki T; Raz A Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049 [TBL] [Abstract][Full Text] [Related]
15. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Nakamura N; Miyagi E; Murata S; Kawaoi A; Katoh R Mod Pathol; 2002 Oct; 15(10):1058-67. PubMed ID: 12379752 [TBL] [Abstract][Full Text] [Related]
16. Heregulin regulation of autocrine motility factor expression in human tumor cells. Talukder AH; Adam L; Raz A; Kumar R Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603 [TBL] [Abstract][Full Text] [Related]
17. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444 [TBL] [Abstract][Full Text] [Related]
18. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278 [TBL] [Abstract][Full Text] [Related]
19. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010 [TBL] [Abstract][Full Text] [Related]
20. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]